Laurence Reid - Nov 23, 2024 Form 3 Insider Report for KalVista Pharmaceuticals, Inc. (KALV)

Role
Director
Signature
/s/ Benjamin L. Palleiko, Attorney-in-Fact
Stock symbol
KALV
Transactions as of
Nov 23, 2024
Transactions value $
$0
Form type
3
Date filed
11/26/2024, 04:39 PM
Previous filing
Sep 25, 2023

No securities are beneficially owned.